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 NEWS SpEciaL fOcuS: MEEtiNg rEpOrt frOM thE cOSt WOrkShOp ON BiOfiLMS
cOSt is one of the longest-running European 
instruments supporting cooperation among 
scientists and researchers across Europe. cOSt 
is also the first and widest European inter-
governmental network for coordination of 
nationally funded research activities. cOSt 
mission is to strengthen Europe in scientific 
and technical research through the support 
of European cooperation and interaction 
between European researchers via the forma-
tion of networks called cOSt actions.
Biofilms were first observed and described 
in 1684 by anthony van Leewenhoek, but 
named centuries afterwards. in a report to 
the royal Society of London he remarked on 
the vast accumulation of microorganisms he 
was able to see in dental plaque: “the number 
of these animalcules in the scurf of a man’s 
teeth are so many that i believe they exceed 
the number of men in a kingdom.” Only many 
years afterwards the significance of microbial 
activity and the economic costs associated 
with biofilms was realized.
Biofilms cost Europe billions of euros each 
year in medical infections, equipment dam-
age, energy losses and product contamination. 
Biofilm is the preferred mode of existence of 
microbes in a range of habitats allowing bac-
teria to survive in hostile environments and 
to colonize new niches by various dispersal 
mechanisms. Being in a community has a lot of 
advantages in comparison to a planktonic life.
however, biofilms also have favorable 
properties; for instance biofilms decompose 
and recycle organic material and help keep 
nutrients circulating in the marine food chain. 
Well-controlled biofilms have potential appli-
cation on biofilteration of industrial waste 
water, bioremediation, formation of natural 
biological barriers for soil and groundwater 
protection from contamination and others.
the Eu has already started strategic ini-
tiatives focusing on biofilms, with topics in 
the framework programme 7. the European 
technology platform on plants for the future 
has in its Strategic research agenda 2025 
Reports from the COST workshop on biofilms
Biofilms: Friend or foe?
Meeting report; June 2011
Ioanna Stavridou1 and Lucia Forzi2; 1Food and Agriculture (FA); 2Chemistry and Molecular Sciences and Technologies (CMST); COST; Brussels, Belgium;  
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(part ii) the development of biofilms to protect 
plants against disease as one of the ways to 
achieve the goal of reduction and optimi-
zation of the environmental impact of agri-
culture. these initiatives are examples of Eu 
efforts to promote activities that can provide 
the means of addressing problems caused by 
biofilms or where biofilms could have a role in 
ameliorating undesirable conditions.
as biofilms is a very diverse subject rang-
ing from medical implant development to 
bioremediation there is an urgent need to 
cross the boundaries of isolated efforts and 
set up a coordinated interdisciplinary network 
able to address the current challenges in a 
more effective way. this will be achieved by 
exchange of knowledge, concepts and work 
and by enhancement of creativity. this need 
for stronger cooperation is acknowledged 
by the recent establishment of well-known 
research centers of biofilms in Europe and 
by the number of conferences organized on 
biofilms. Nevertheless, there is still no fora to 
bring the relevant scientists together in a more 
systematic and effective way.
in order to stimulate the formation of such 
an interdisciplinary forum able to tackle cur-
rent and future challenges on biofilms in an 
increasingly globalized world, cOSt (European 
cooperation in Science and technology; www.
cost.eu) organized a multidisciplinary two-day 
Exploratory Workshop on “Biofilms: friend or 
foe?” in June 2011.
the two-day invitation-only workshop took 
place in Berlin, germany and attracted around 
50 participants from 18 countries, mostly from 
Europe but also from the uS, australia, New 
Zealand, South africa, Sri Lanka and others. 
the workshop was divided in four sessions 
focusing on cell signaling (within a biofilm 
and cross-kingdom interactions), novel bio-
tech and bioengineering applications (envi-
ronmental, agricultural and medical), industry 
priorities and future perspectives. a poster ses-
sion also allowed scientists to exchange views 
and ideas during the walking lunches.
the first day started with a welcome 
address by the Scientific Organisers from cOSt 
Office, Lucia forzi (Science Officer, chemistry 
and Molecular Sciences and technologies) and 
ioanna Stavridou (Science Officer, food and 
agriculture), followed by an opening address 
by henk van Liempt of the german federal 
Ministry of Education and research (BMBf). 
the cOSt framework, its mission and goals 
were outlined in the presentation given by 
ioanna Stavridou. then philip Stewart (Director 
of the center for Biofilm Engineering at 
Montana State university) gave an overview 
on the concept of biofilms and their antimicro-
bial tolerance illustrating different phenomena 
such as diffusion of antibiotics into biofilm, 
hydrodynamics around the biofilm, dormancy 
(persister cells that can reseed community 
after catastrophe) and physiological heteroge-
neity in biofilm cell populations.
the first two sessions of the workshop 
focused on cell signaling. Since biofilms are 
extremely relevant in medicine and in bio-
technology, it is fundamental to study how 
bacteria switch from a planktonic, individual-
ized lifestyle, to biofilms. the sessions that 
focused on signaling within a biofilm high-
lighted the importance of intra- and inter-
bacterial communication and information 
exchange. Various topics were addressed 
going from the production of interference 
molecules involved in competition interac-
tions within multispecies biofilm communi-
ties, to the production, release and response 
to signal molecules in quorum sensing signal-
ing and to the role of the signaling molecule 
cyclic-di-gMp on biofilm formation. the sec-
ond session on cross-kingdom interactions 
was dedicated to signaling and interaction 
between organisms of different kingdoms 
and on potential applications to biofilm regu-
lation or control. interactions between biofilm 
bacteria and (1) plants (specific factors for 
adhesion and biofilm formation and relevant 
application for biocontrol to contain plant 
infections), (2) barnacles and macro-algae 
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(use of quorum sensing molecules produced 
by marine bacterial biofilms as cues to locate 
surface for settlement thereby influencing 
the development and functioning of bio-
fouling communities), (3) fungi (the nema-
tode Caenorhabditis elegans as model host 
to identify genes and functions of funda-
mental relevance for pathogenesis and to 
screen in vivo for anti-fungal compounds) and 
(4) humans (quorum sensing inhibition as a 
strategy against pathogenic bacteria biofilms) 
were presented.
the first session of novel biotech and bio-
engineering applications addressed different 
technologies with important environmental 
applications. it was opened by addressing 
the important role of biofilm monitoring, pre-
senting an overview of the most advanced 
examples of monitoring devices used in drink-
ing water networks and to evaluate clean-
ing measures. in the following presentations 
different beneficial biofilm innovative tech-
nologies were presented. the various applica-
tion areas included waste water treatment 
plants (i.e., granular sludge), degradation of 
persistent pollutants (i.e., pcB), controlled anti-
fouling with conductive paints supported by 
growth inhibiting nanoparticles, and biofuel 
cells using electroactive biofilms (relevant to 
bioremediation, bioelectricity production and 
environmental sensing). to conclude, alter-
native nanotechnology methods were pre-
sented focusing on the use of nanofibers, 
produced by electrospinning, with antimicro-
bial and antifouling properties. the second 
day started with a presentation by tomasz 
calikowski (European commission) where he 
gave an overview of the fp7 theme 2 and call 
proposals for 2012. this was followed by the 
session on Novel Biotech and Bioengineering 
applications in agriculture. During this ses-
sion different issues were addressed including 
positive applications of biofilms, i.e., as biofer-
tilizers, that could increase crop yields, reduce 
inputs of chemical fertilizers, pesticides and 
reduce harvest loss. the biofilms as a friend 
concept was then followed by two presenta-
tions dealing with the negative aspects of 
biofilms, one in inflammations in dairy cows 
and another in food processing, and innova-
tive technologies to control their detrimental 
effects. for instance, vaccination of cows with 
strong biofilm-producing bacteria express-
ing the Slime associated antigenic complex 
(Saac) confers protection against infection 
and mastitis, whereas natural-derived prod-
ucts (e.g., essential oil and hydrosol) may be 
equally effective for sanitation purposes as 
the currently used chemical ones. this session 
was closed by Winy Messens (EfSa) present-
ing the principles of risk analysis in food and 
feed safety and in particular the activities of 
the Biological hazards (BiOhaZ) panel that 
focuses among other topics on antimicrobial 
resistance.
in the session of Novel Biotech and 
Bioengineering applications in Medicine the 
opening lecture highlighted the relevance 
of biofilms in clinical microbiology and 
pathogenesis of biofilm-related infections, 
whereas the presentations that followed were 
focused on potential strategies to control 
biofilms, with the use of phages, enzymes 
that degrade the extracellular polymeric 
substances composing the biofilm matrix, 
essential oils and terpenes and nanoparticles 
as function of biocidal, anti-adhesive and car-
riage capabilities.
the third session on biofilms-related pri-
orities in industry included an overview on the 
development of new agents for prevention, 
treatment or management of biofilm-associ-
ated infections and of biofilm development on 
abiotic surfaces. these new agents included 
among others antibiotics, microbiocides, 
enzymes and even bacterial strains that form 
thin or no biofilms but can inhibit the growth 
of more harmful biofilms. this session was of 
high value because industry representatives 
had the opportunity to discuss with highly 
qualified researchers the need for diagnostic 
and monitoring technologies for detecting the 
presence of biofilms and possible strategies for 
identifying new solutions to problems caused 
by biofilms.
the last session of the workshop consisted 
of a presentation by Lucia forzi focusing on 
the fact that cOSt provides a platform for 
European scientists to cooperate on a par-
ticular project, an action, and which steps 
researchers who wish to launch a new action 
have to follow. the workshop ended with a 
round table discussion on possible future co-
operations among the researchers and indus-
try representatives present.
Biofilms are recognized to be a critical and 
hard to remove contamination source. the 
presence of a biofilm results in a number 
of dangers for human health or industrial 
activities: hygiene and food safety in the food 
industry, nosocomial diseases in hospitals, 
clogging and contaminations in water sys-
tems including cooling systems, pipes corro-
sion, boat-hulls fouling, etc. Many branches 
of industry or healthcare services attempt to 
control biofilm by chemical shocks (acid, base 
and disinfectant). But this has been proved to 
be inefficient in removing entirely the biofilm, 
presenting furthermore a high aggressiveness 
for materials. following a two-year research 
project, rEaLcO and the iNra (french National 
institute for agricultural research) developed 
an enzyme-based process to remove biofilms 
from surfaces in numerous applications. that 
process, involving a specific enzyme cocktail 
and a detergent phase, showed high efficiency 
at both lab and pilot scale on different bio-
films, before it now reaches proved success in 
industrial applications.
Biofilms
a biofilm is a viscous slime layer that devel-
ops on almost every surface in contact with 
water and microorganisms. it is composed 
of bacteria and organic polymers called EpS 
(Extracellular polymeric Substances, mainly 
polysaccharides and proteins) that promote 
the irreversible adhesion of microorganisms 
and create a protective and evolving structure 
around them. the biofilm is thus a reservoir 
of microorganisms that protects them from 
external aggressions, among which are clean-
ing and disinfection.1
Research Program
rEaLcO and its partner iNra realized a two 
year project, starting October 2006, spon-
sored by the Euraka agency. the first step 
of that project focused on the selection of 
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microorganisms developing rapidly a biofilm 
colony. all microorganisms were originated 
from different food industries. these biofilms 
were then tested for their resistance to soft 
cleaning procedures and mechanical removal, 
with the goal of selecting the toughest biofilm 
on which to work. for this purpose, a spe-
cific screening method was developed that 
ended with the selection of six bacterial strains 
from different bacterial families. the second 
step of the project targeted the selection of 
enzymes activities for their ability to degrade 
EpS and biofilms. the composition of a deter-
gent phase has also been screened in order 
to create a medium (i.e., cleaning solution) 
increasing the efficiency of enzymes. Biofilms 
were developed on stainless steel slides and 
enzymatic solutions were used to remove bio-
films in a cleaning-in-place procedure, first at 
lab scale and then in an industrial pilot instal-
lation. results showed that different enzyme 
activities were more or less efficient on differ-
ent bacteria strains originated biofilms.2 this 
research program ended with the selection of 
a detergent phase and a multi-activity enzyme 
cocktail able to degrade a broad variety of 
biofilms.
The Enzyme-Based Process
the interest of an enzyme-based solu-
tion for biofilm removal relies on the action 
the selected enzymes have on biofilm. the 
selected cocktail targets the degradation of 
the biofilm EpS matrix. No biocide effect is 
sought on biofilm microorganisms. indeed, 
what makes a biofilm resistant to cleaning and 
disinfection procedures, originating biofilm-
linked concerns, is precisely the EpS matrix. as 
this matrix is composed of organic macromol-
ecules, the right enzymes activities are able 
to degrade those structural components and 
to weaken the biofilm structure. Once partly 
degraded, the biofilm matrix is on one hand 
more easily removed by mechanical effect 
(flow, pressure, brushing) and on the other 
hand, is less protective for microorganisms 
that are then more efficiently attacked by a 
disinfection procedure.
these two actions result in the complete 
removal of the biofilm from the surface. Figure 
1 illustrates this.
a biofilm (Bacillus cereus) has been devel-
oped on the faces of a stainless steel ring that 
is in a second step introduced in a pipe show-
ing a broader section than the ring. the sud-
den section change encountered by the flow 
when reaching the ring creates a perturbation 
zone, reducing mechanical forces and clean-
ing agent efficiency, and so usually favor-
able to the development of biofilm in closed 
installations. Different cleaning solutions have 
been circulated in the pipe and the biofilm 
removal efficiency followed by microorgan-
isms enumeration on the ring surface and by 
fluorescence microscopy analyses. Figure 1A 
shows the biofilm structure on the stainless 
steel ring after incubation (5.34E+06 cfu). 
the EpS matrix is visible. Figure 1B shows the 
ring surface after a cleaning procedure with 
caustic soda (0.5%, 30 min at 45°c). a part of 
the biofilm has been removed (5.2E+04 cfu) 
but what is left on the surface is still the entire 
biofilm structure. So the EpS matrix is still pro-
tecting microorganisms. Figure 1C shows the 
ring surface after a cleaning procedure with 
Figure 1. Bacillus cereus biofilm developed on a stainless steel surface, after 48 h incubation (a) 
and after subsequent application of caustic soda (B) and enzymatic (c) cleaning procedures. 
[iNra-ur638, Y. Lequette, c. faille (contrat NEtZYM)].
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the enzyme-based solution (detergent phase 
0.5%, enzyme cocktail 0.05%, 30 min at 45°c). 
the biofilm matrix has been entirely removed 
and only bacteria’s cells are visible (1.32E+03 
cfu).the first conclusion is the much better 
efficiency of enzymes to remove biofilm EpS. 
the second conclusion is the understand-
ing of the different efficiency levels that a 
disinfection step, realized with any classical 
disinfection means, will reach after one or 
the other cleaning step. a disinfectant media 
applied on the surface treated with caustic 
soda will face the EpS structure that will pre-
vent it reaching bacteria’s. it will then be inef-
ficient and these microorganisms contained 
in the biofilm will be able to continue their 
growth. On the other hand, a disinfection step 
applied on the surface cleaned with enzymes 
will directly reach bacteria cells that have no 
protection means anymore. the efficiency will 
be much greater on cell destruction, leading 
to a much cleaner and less contaminated 
surface. the biofilm concern would then be 
solved.
Field Application
this enzyme-based solution is now applied 
in different industries, in various application 
fields (water, catering, food processing, heat 
exchangers). Most frequent demands for bio-
film removal come from the food industry, 
where biofilm presence leads to finished prod-
uct contamination and important production 
losses due to contaminated finished product 
destruction. another field for which biofilm 
removal has a crucial importance is hospitals, 
where about 65% of the nosocomial diseases 
are linked with biofilms.
Biofilm removal on site requires different 
steps and expertise:
Biofilm detection. a biofilm has to be 
clearly identified as the contamination source 
and must be located in order to realize a 
targeted treatment. Various methods exist to 
detect a biofilm in closed installations, all 
requiring experience for results analyses. No 
method was available for biofilm detection 
on open surfaces. rEaLcO developed a spe-
cific coloration method to answer portability, 
rapidity, accuracy and specificity requirements 
for biofilm detection at industrial scale.
Cleaning protocol. a complete protocol, 
adapted to the installation/equipment speci-
ficity and materials encountered has to be set 
up. usual sequence is: previous classic clean-
ing procedure/rinsing/biofilm removal treat-
ment/rinsing/disinfection step/rinsing.
Enzymatic biofilm removal processes exist 
for both open plant cleaning and cleaning-in-
place procedures.
Proof of biofilm removal. another biofilm 
detection step is required to prove the effec-
tive biofilm elimination.
Prevention treatment set-up. as biofilm 
development cannot be avoided, a regular 
application of the anti-biofilm specific process 
has to be applied to secure the installation 
against biofilm recontamination. the fre-
quency of this treatment is evaluated for each 
case depending on the biofilm development 
rapidity, which depends on contamination 
source, available nutrients, medium conditions 
and cleaning procedures.
the results and benefits achievable at 
industrial scale are mainly measurable on pro-
ductivity and related profitability. Lower con-
tamination levels in finished products allow 
important savings by reducing the need of 
contaminated finished product destruction. 
a global improvement of hygiene results has 
also been measured in different industries. 
product quality is also improved when unde-
sired contaminations lead to product organo-
leptic quality modification, even not being a 
danger for health. finally, reducing the risk of 
contaminations represents an important ben-
efit regarding food safety and human health.
Conclusions
in the healthcare sector and/or in many indus-
trial fields, biofilms represent a threat for 
human health, and to another level, for profit-
ability. this threat is directly represented by 
the bacteria’s reservoir biofilms are. But what 
creates the threat and makes it long-lasting 
and always pending is the resistance of biofilm 
to cleaning and disinfection procedure. a spe-
cific enzyme-based treatment offers a reliable 
and sustainable solution. By targeting the EpS 
matrix, adhesive armorplate protecting the 
biofilm, enzymes achieve to weaken biofilm 
structure and promote its entire removal from 
contaminated surfaces.
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the world is facing formidable challenges in 
meeting the rising demands of potable water 
and consumer products. the health and wel-
fare of people are closely connected to the 
availability of adequate, safe and affordable 
water supplies. also cost-effective recovery 
methods of chemicals and resources from 
waste and wastewater play an increasing role 
in sustaining human civilization on Earth. Many 
of these processes are based on microbial 
biofilms.1
One of the major hazards humanity is facing 
is existing and new environmental pollution 
of our foundations and primary resources of 
life—air, water and soil—by (eco)toxic chemi-
cals. there is now overwhelming evidence 
that human health is directly dependent on 
the state of our environment. chemical pol-
lutants from the environment, apart from hav-
ing other effects, are the cause of or provoke 
many human diseases. consequently, we need 
a better balance between disease-centered 
(therapy) and environment-centered (preven-
tion) research. Of particular concern is the 
pollution of the aqueous environment with, 
e.g., carcinogens, hormones or hormone-like 
substances, pesticides and antibiotics.2 this is 
a major contribution to the increasing loss of 
the already inadequate supply of safe drinking 
water in most countries and results—at the 
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best, for those who can pay—in the neces-
sity of expensive treatment. We can never 
approach sustainable development, a goal 
constantly reiterated by almost all govern-
ments, if we do not find ways and means of 
eliminating existing toxic chemicals from the 
environment and also prevent new chemicals 
entering it and control their use at the source.3
Environmental biotechnology, which was 
restricted in the early 80s to the traditional 
biological wastewater treatment processes, 
has experienced a tremendous development 
in the last two decades. impressive progress 
was made particularly in biodegradation and 
bioremediation research. in many cases it was 
shown that this technology is able to per-
manently eliminate pollutants inexpensively, 
especially the highly problematic pollutants 
present in low but toxicologically relevant 
concentrations.4 probably the best example 
for this is the striking commercial success of 
air and off-gas cleaning by biological filters, 
a field in which many companies have estab-
lished and the technology has proven to be 
cheap and reliable when compared with the 
alternative incineration technology.5,6 Many 
other bioremediation processes are now at the 
level of scaling up and Nature Biotechnology 
has published in 2003 that bioremediation is 
the fastest growing sector in the hazardous 
waste industry in the uS (a $7–8 billion turn-
over annually).
Energy and feedstock materials for the 
industry are in increasing demand. With con-
straints related to availability and use of oil, the 
energy and chemical industry is undergoing 
considerable changes. the need for the use of 
cheaper and widely available feedstocks, and 
the development of sustainable and environ-
mentally friendly chemical processes is rapidly 
growing under both economical and public 
pressure.7 therefore, treatment of wastewaters, 
waste gas and solid waste need to be gradu-
ally integrated into process design. instead 
of discharging their waste into the environ-
ment, industries need to become increasingly 
self-sufficient and recover compounds from 
their own wastestreams or use (upgraded) 
wastestreams of neighboring industries as raw 
material. Many biofilm based environmental 
biotechnological processes support these 
developments.
Sustainable waste treatment concepts are 
under development with environmental bio-
technology as key component, and can lead to 
the recovery of useful by-products like chemi-
cals in the form of e.g., fertilizers (ammonia, 
phosphates), raw materials (elemental sulfur 
and selenium, sulfuric acid,...) or energy (bio-
gas, hydrogen or electricity). Obviously, add-
ing value to waste by upgrading the recovered 
compounds will only be a reality if it is demon-
strated that there is a fundamental basis and a 
tangible advantage in using these recovered 
compounds rather than buying raw materials 
and feedstock.8
it is common knowledge that environmen-
tal protection is simply and purely legislation 
driven. Ergo, the main barriers for develop-
ment, acceptance and penetration of existing 
and new technologies are the lack of appropri-
ate environmental legislation. Establishing and 
enforcing appropriate environmental legisla-
tion, together with a good strategy for finan-
cial incentives for start-up activities, would 
provide the economic basis for such technol-
ogy, and hence, would also create jobs in this 
area. if there is no legislation, the environment 
is ‘exploited’ and used in a non-sustainable 
way. an important aspect of this legislation 
would include an internalization of environ-
mental costs in prices of goods produced and, 
consequently, also the taxing of (produced 
and imported) products in which these costs 
are not included.
policy should at this moment draw the 
attention of the public to the dangers of hav-
ing insufficient environmental technologies. 
for instances, we seem to have no answer to 
the increase of cO2, to the presence of endo-
crine disrupters at ng/L everywhere in the 
environment, and so on. hence, we need to 
continue our search so that we in the future 
have tools to deal with these environmental 
challenges also. One of the most pressing 
areas to support sustainable development is 
the generation and use of renewable energy 
from solar, wind or wave energy, an area linked 
tightly with global warming and cO2 seques-
tration. Several of the existing or prospec-
tive technologies involve biotechnology, e.g., 
microbial fuel cells, biogas or biohydrogen 
production from (waste) biomass.3 focused 
support of these technologies will link the 
rapidly developing biotechnology r&D to the 
conservative transport and energy sector.
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transition metal oxides (tMO) electrodes pro-
vide a suitable platform for spectroscopy- and 
microscopy-based investigation of viable elec-
troactive biofilms (EaBs). commercially avail-
able tMOs, such as indium titanium oxide 
(itO), are produced from rare and expensive 
elements. thus, there is a significant need to 
explore alternative technology to meet the 
demand. ZnO-based tMOs are low-cost and 
have excellent electrochemical properties. in 
this study, we report for the first time a model 
EaB of Shewanella loihica pV-4 on ZnO films 
deposited on perspex substrates via pulsed 
laser deposition (pLD). commercially available 
itO electrodes were also used for comparison. 
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EaB electroactivity was characterized through 
microbial biofilm voltammetry (MBV). itO and 
ZnO films show flat surfaces and amorphous 
structure, and have 60 and 105 /sq. sheet 
resistance, respectively. S. loihica pV-4 biofilms 
on itO and ZnO produced maximum current 
density of 3.38 and 0.25 ma/cm2, respectively. 
Our results suggest that ZnO has potential for 
the growth and characterization of EaBs.
Introduction
Electroactive biofilms (EaBs) conserve energy 
through extracellular electron transfer (EEt) 
to insoluble electron acceptors such as metal 
oxides and electrodes.1 Depending on the 
electrochemical potential and the availability 
of soluble electron donor and acceptor, the 
EEt may occur from the EaB to the electrode 
or vice versa; the former are often termed 
cathodic EaBs and the latter anodic EaBs, 
respectively. in this study, we focused on 
anodic EaBs, due to their relevance to micro-
bial fuel cells, biosensors, wastewater treat-
ment and biosynthesis of bulk chemicals.2-5
Well-known EaBs-forming microorgan-
isms include gram-negative geobacter and 
Shewanella genus. EaBs are usually grown at 
the working electrode of potentiostat-con-
trolled electrochemical cells (Ecs), where the 
potential can be set with great accuracy and 
the electron flow at the interface EaB/elec-
trode can be measured with high precision.6 
the thermodynamic and the kinetics of the 
EEt process are studied by direct electrochem-
istry methods, such as chronoamperometry 
(ca), cyclic voltammetry (cV), and electro-
chemical impedance spectroscopy (EiS).7
however, electrochemical methods alone 
cannot reveal the nature of EEt agents. 
Spectroscopy is needed for this purpose. Such 
analysis is best performed when the EaBs are 
grown on an optically transparent conductive 
substrate,5,8 among which only itO has been 
used to grow EaBs.5 thus, research into eco-
nomically viable and environmentally friendly 
materials for the routine investigation of EaBs 
is needed. in this work, we characterize a 
model anodic EaB of Shewanella loihica pV-4 
on ZnO and commercial itO thin films. ZnO 
thin films were grown using pLD on acrylic 
glass.9 We characterized the electroactivity 
of Shewanella loihica pV-4 biofilms through 
MBV.7 the surface topography, crystallinity and 
electrical properties of both ZnO and itO 
thin films were determined using atomic force 
microscopy (afM), x-ray diffraction (XrD), and 
four-point probe i-V. the suitability of ZnO and 
itO films as substrate materials for the charac-
terization of anodic EaBs is discussed.
Experimental Details
ZnO and ITO thin films. itO thin films depos-
ited on polyethylene terephthalate (pEt), with 
sheet resistance of 60 /sq and film thick-
ness of 150 ± 25 nm were purchased from 
Sigma aldrich (caS 50926–11–9). the ZnO 
thin films were prepared in our laboratory on 
20 mm x 5 mm perspex substrates using a 
conventional pLD system.9 the cleaned sub-
strates were placed in a vacuum chamber 
filled with pure oxygen at 3 x 10-8 mbar and 
at 5 cm from the surface of a high-purity ZnO 
target. a short-pulse (6 ns) of uV laser light 
(266 nm) from a frequency-quadrupled Nd:Yag 
laser was focused onto the ZnO target with a 
fluence of 2.0 J/cm2 to produce the expand-
ing ZnO plasma which recondensed on to the 
perspex substrate forming the ZnO thin film. 
the laser was operated at a repetition rate of 
10 hz and all the depositions were performed 
at room temperature in varying ambient pres-
sures ranging from 0.1 to 0.4 mbar. a calibra-
tion curve of the film thickness as a function 
of the number of laser shots was constructed. 
the growth rate in the above conditions was 
found to be linear over the range 150–2,000 
nm and equal to 0.03 nm/shot.
ZnO and ITO thin film characterization. 
the surface morphology, roughness, sheet 
resistance, crystallinity and hydrophobicity of 
itO and ZnO were studied using the following 
techniques/methods: afM in tapping mode, 
four-point probe (van der pauw) current- 
voltage measurements, XrD (θ–2θ) scans with 
the cu ka wavelength of 0.154 nm, and water 
contact angle with a commercial goniometer, 
respectively.
Biofilms formation and characterization. 
Shewanella loihica pV-4 strain (DSM 17748) 
was subcultured10 and a three-electrode Ec 
used4 as previously described. the working 
electrode (ZnO or itO coated) was connected 
to the current collector using platinum wire 
and miniature nylon screws. platinum wire 
was used as a counter electrode and a ScE 
was connected to the Ec via a salt bridge. the 
assembled Ecs were autoclaved prior to the 
insertion of the working electrode. all Ecs 
were operated under a constant flow of sterile 
humidified N2. the Ecs were maintained at 
30°c and mixed via a magnetic stirrer, which 
was activated during ca and inactivated dur-
ing cV. after inoculation, the Ecs were covered 
with aluminum foil to prevent exposure to 
ambient uV light and the consequent forma-
tion of reactive oxygen species (rOS) on ZnO 
surface. in all experiments, lactate was added 
as electron donor to the non-limiting concen-
tration of 20 mM.
the Ecs were connected to a multichannel 
potentiostat (Bio-Logic, france). Both itO and 
ZnO electrodes were tested under identical 
experimental conditions. the parameters for 
each method were: (a) cV: scan rate = 1 mV/s, 
Ei = -0.8 V vs. standard calomel electrode (ScE), 
Ef = 0 V vs. ScE; (b) ca: E = 0.2 V vs. ScE.
Results and Analyses
the afM topography of commercial itO and 
ZnO thin films are shown in Figure 1A and B, 
respectively. the ZnO and itO thin films were 
homogeneous. Small cracks were occasionally 
present on the surface of the ZnO films, with 
typical depth of 10 nm. Such cracks appeared 
in samples that were annealed at 100°c. Both 
the itO and ZnO surfaces appear free from 
large aggregates, particulates and pinholes, 
however, their rms roughness differ mark-
edly, being 12 nm and 2.2 nm, respectively. 
Figure 1C shows the sub monolayered biofilm 
of S. loihica pV-4 on itO whereas Figure 1D 
shows a more uniform multilayered biofilm of 
S. loihica pV-4 on ZnO.
the sheet resistance of itO films was on 
average 60 /sq, while that of ZnO films was 
approximately 1000 times larger, as expected 
for nominally undoped ZnO material.11 
a weak dependence of the films resistivity 
on the ambient pressure during growth was 
also observed. the ZnO films with the lowest 
resistivity were chosen for EaB growth and 
characterization.
the XrD data for the itO and ZnO films 
are shown in Figure 2A and B for ZnO with 
thickness of 136 nm, 1180 nm and 1720 
nm. Only a strong pEt peak at 2θ ≈26.0° is 
seen in Figure 2A indicating that the itO 
has an amorphous structure.11 from Figure 
2B, we see that the 136 nm thick ZnO film 
is also amorphous, whereas the presence of 
a single peak at 2θ ≈34.7° indicates good 
crystallinity of the 1180 nm and 1720 nm 
thick ZnO films, with the wurtzite structure 
and c-axis orientation, i.e., the (0001) wurtzite 
planes lie parallel to the perspex surface.
the water contact angle was measured at 
74 ± 1.2° for the itO film, indicating that its 
surface is hydrophilic. for the 136 nm thick 
ZnO film, this angle was measured at 92 ± 
2.0°, which means that the surface is slightly 
hydrophobic.
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a typical ca for S. loihica pV-4 on the itO 
electrode is shown in Figure 3A. following 
inoculation of the suspended cells, the anodic 
(oxidation) current decreased. the spent 
growth medium was changed daily with fresh 
medium, in order to promote biofilm growth. 
following the second medium change (Mc), 
the anodic current started increasing as a 
result of the catalytic oxidation of lactate in 
the EaB, as previously described.6 the current 
density reached a maximum value of 3.5 ma/
cm2 (n = 3) after 90 h. the sudden drops in the 
current density observed after 62 h and 85 h, 
respectively, are likely due to the exhaustion 
of the lactate in the medium and/or to a ph 
change due to accumulation of metabolic end 
products.12 the cV of S. loihica pV-4 biofilm 
on itO electrode showed a typical sigmoidal 
curve (Fig. 3B) with very low hysteresis, as 
reported earlier for other EaBs grown on itO.8 
this result corresponds to the catalytic (turn-
over) EEt at the EaB/electrode interface.
the current density obtained for S. loihica 
biofilms grown on ZnO did not reach a plateau 
as observed on the itO electrode (Fig. 3C) and 
had a maximum value of 0.25 ma/cm2 (n = 2) 
after approximately 50 h. the cV curve showed 
small sigmoidal behavior and overlapped with 
the redox peaks of the microbially produced 
flavins, centered at -0.35 V vs. ScE (Fig. 3D). 
Medium change had no effect on ca and cV 
behaviors, indicating that the current decrease 
was not caused by the exhaustion of the lac-
tate. afM images of S. loihica pV-4 biofilms 
grown on ZnO show a uniform multi-layered 
structure, whereas biofilms on itO appear sub-
monolayered (Fig. 1C and D).
these results indicate that facultative EaB-
forming microorganisms such as S. loihica pV-4 
can grow on ZnO thin film electrodes and 
produce a small but significant oxidation cur-
rent. however, the EEt rate on ZnO is much 
lower than that measured on an itO electrode. 
this can be attributed in part to the higher 
hydrophobicity of the ZnO films. it is also 
possible that the lower surface roughness of 
ZnO films prevent adsorption of S. loihica pV-4 
membrane cytochromes on the electrode,13 
thus decreasing the overall oxidation current. 
although ZnO has known antimicrobial prop-
erties due to formation of reactive oxygen 
radicals at the interface,14 the growth of well 
structured Staphylococcus epidermidis biofilms 
on ZnO films, identical to those used in this 
study, has been recently documented.15 in the 
present case, it is possible that free-oxygen 
radicals prevent the growth of the facultative 
anaerobe S. loihica pV-4 due to the partial dis-
ruption of the cell membrane thereby decreas-
ing the oxidation current.
finally, the relatively high value of the 
electrical resistivity of the ZnO material used 
in the present work may have a limiting influ-
ence on the current production at the EaB/
electrode interface. this drawback could be 
easily circumvented by suitable metal doping 
to produce ZnO material with lower resistivity.
Conclusions
this work showed that ZnO deposited on plas-
tic substrates using pulsed laser deposition are 
suitable for electrochemical characterization 
of facultative EaB forming strains. ZnO thin 
films with increased hydrophobicity and lower 
resistivity may result in higher EEt at the inter-
face biofilm/electrode.
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a diverse range of microorganisms, of which 
bacteria are the most predominant, colonize 
and grow on the surfaces of the oral cavity. the 
largest accumulations of bacteria are found as 
biofilms on the tooth surface (dental plaque) 
while on mucosal surfaces epithelial turnover 
controls the microbial load. Dental plaque was 
probably the first biofilm to have been studied 
with respect to its microbial composition and 
sensitivity to antimicrobial agents. it is now 
one of the best-studied biofilms displaying 
all of the typical characteristic features. the 
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presence of dental plaque is regarded as natu-
ral and essential to the normal physiologi-
cal development of the oral cavity. however, 
microbial homeostasis in dental plaque can 
be disrupted and disease occurs including 
dental caries and gingivitis. as part of the 
resident oral microflora, dental plaque acts as 
an important component of the host defenses 
by excluding exogenous populations through 
colonization resistance and contributes to the 
regulation of the inflammatory host response 
to commensal bacteria. recent studies have 
also shown the nitrate reducing activity of the 
oral microflora to be a key factor in the pro-
duction of beneficial antimicrobial and vaso-
active molecules. Oral healthcare products 
should therefore attempt to control the levels 
of plaque rather than attempting to eliminate 
it, so as to retain the beneficial properties. 
control of dental plaque-related diseases has 
traditionally relied on non-specific removal 
of plaque by mechanical means. however, as 
our knowledge of oral disease mechanisms 
increases, future treatment is likely to be 
more targeted, for example at small groups 
of organisms, single species or at key vir-
ulence factors they produce. the potential 
of nanoparticles to control the formation of 
biofilms within the oral cavity, as a function 
of their biocidal, anti-adhesive and carriage 
capabilities is also coming under scrutiny. 
thus, more effective products that are able to 
improve clinical efficacy while preserving the 
beneficial aspects of the normal oral micro-
flora are likely to be the development goals 
in the future.
Cell-to-cell communication (quorum sensing) 
Steve Atkinson; Molecular and Cellular Bacteriology; The University of Nottingham; Nottingham, UK; Email: steve.atkinson@nottingham.ac.uk
Yersinia pseudotuberculosis biofilm develop-
ment on Caenorhabditis elegans is regulated 
by quorum sensing-dependent repression of 
the type iii secretion system. Many gram-
negative bacteria employ a cell population 
density dependent regulatory system known 
as quorum sensing (QS) that couples gene 
expression with growth phase to control a 
variety of virulence-associated phenotypes. 
these systems are dependent on the synthe-
sis and transduction of N-acylhomoserine lac-
tone (ahL) signal molecules and in the human 
pathogenic species of Yersinia ahL synthase 
orthologs of Luxi (ahL synthase) and Luxr 
(response regulator) have been identified in 
Yersinia pseudotuberculosis (ypsr/i, ytbr/i), 
Yersinia enterocolitica (yenr/i) and Yersinia 
pestis (yper/i, yepr/i). We have shown that 
Y. pseudotuberculosis and Y. enterocolitica syn-
thesize long and short chain ahLs and that QS 
is important for activating flagella-mediated 
motility which, in Y. pseudotuberculosis acts 
by regulating the expression of two key regu-
lators, flhDc and flia. Y. pseudotuberculosis 
and Y. pestis form biofilms on the surface of 
the nematode worm Caenorhabditis elegans 
and this tractable host-pathogen model is 
therefore an important tool for examining 
biofilm development on biotic, motile sur-
faces. We show that Y. pseudotuberculosis 
biofilm development on C. elegans is gov-
erned by ahL-mediated QS since biofilms 
are attenuated when nematodes are infected 
with Y. pseudotuberculosis expressing an ahL-
degrading enzyme or when the ahL synthase 
or response regulator genes respectively 
are mutated. Similarly, when motility genes 
such as flhDc, flia and flha are mutated bio-
films are also attenuated. While examining 
whether the flagella export apparatus was 
involved in the biofilm phenotype SDS-pagE 
revealed that several proteins associated 
with the type three secretion (ttS) system 
were upregulated in motility mutants in a 
temperature and calcium independent man-
ner. Similar observations were made for the 
Y. pseudotuberculosis QS mutants indicating 
that the ttS virulon is repressed by QS. By 
curing the virulence plasmid or by introduc-
ing a yscJ mutation we then showed that 
biofilms can be restored in flhDc and ypsi/
ytbi mutants. taken together these data 
show that biofilm formation is dependent on 
QS-dependent repression of ttS.
Cyclic-di-GMP signaling and biofilm formation of Escherichia coli
Gisela Becker-Klauck* and Regine Hengge; Institut für Biologie – Mikrobiologie; Freie Universität Berlin; Berlin, Germany; *Email: gisbeck@zedat.fu-berlin.de
the ubiquitous bacterial signaling mole-
cule cyclic-di-gMp, which is produced and 
degraded by diguanylate cyclases (carrying 
ggDEf domains) and specific phosphodies-
terases (EaL domains), respectively, regulates 
transitions between the motile-planktonic and 
sedentary biofilm “life-styles.”1 c-di-gMp con-
trols a variety of targets, including transcrip-
tion and the activities of enzymes and complex 
cellular structures. Many bacterial species pos-
sess many ggDEf/EaL proteins (29 in E. coli), 
which has lead to the concept of temporal and 
functional sequestration of c-di-gMp control 
modules.1 Some ggDEf/EaL domain proteins 
(four in E. coli) have degenerate ggDEf/EaL 
motifs, are enzymatically inactive and can act 
by direct macromolecular interactions. in E. 
coli, c-di-gMp signaling is tightly integrated 
with the general stress response, as many 
ggDEf/EaL genes are regulated by rpoS.3 
Moreover, c-di-gMp-dependent down-regu-
lation of motility and induction of biofilm-
associated functions such as the production 
of (auto)adhesive curli fimbriae occur during 
entry into stationary phase and require rpoS.2 
the talk will present an overview of the 
molecular mechanism of switching from motil-
ity to adhesion, which is based on a mutual 
inhibition of the flhDc/motility and rpoS/
csgD/curli control cascades involving c-di-
gMp signaling, and the molecular function 
of a degenerate EaL domain protein, which 
acts as a direct anti-repressor in a pathway 
that modulates biofilm architecture.4 taken 
together, these studies have also generated a 
novel general concept of the evolution of com-
plex bacterial second messenger signaling.1
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Biofilms and their significance in clinical microbiology
Gianfranco Donelli; Microbial Biofilm Laboratory; IRCCS Fondazione Santa Lucia; Santa Lucia, Italy; Email: g.donelli@hsantalucia.it
in spite of the large amount of experimental 
data currently available, a number of open 
issues is still to be addressed on the sig-
nificance of the microbial biofilms in clini-
cal microbiology and in the pathogenesis of 
biofilm-based infections, including:
(1) the disclosure of interaction mecha-
nisms in multispecies biofilms;
(2) the validation of a model to explain 
the higher antimicrobial resistance of biofilm-
growing microorganisms;
(3) the detection of specific agents able 
to disrupt mature biofilms or to interfere with 
quorum sensing phenomena;
(4) the finding of advanced anti-biofilm 
materials to prevent biofilm-based device-
related infections.
Even if gibbons and Nygaard described 
since 1970 the co-aggregation as a specific 
phenomenon of recognition and mutualis-
tic or competitive interaction among differ-
ent species in the oral cavity, most of the 
investigations have concerned single- 
species biofilms, so disregarding the pivotal 
role of multispecies biofilms in causing acute 
and chronic infections in the respiratory, gas-
trointestinal and genitourinary apparati.
anyway, single- and multispecies biofilms 
are difficult to eradicate with conventional 
antibiotics. in fact, an antimicrobial resistance 
10–1,000 times higher has been observed in 
sessile growing microrganisms in comparison 
with the planktonic forms. however, we haven’t 
so far a general model able to properly take 
into account our present knowledge on the 
higher antimicrobial resistance of biofilm-grow-
ing microorganisms, even if the occurrence of 
the following phenomena has been reported: 
(1) the reduced and slow antibiotic penetra-
tion due to the physical barrier represented by 
microbial exopolysaccharides; (2) the high con-
jugation frequency that promotes the exchange 
of plasmids, including genes coding for mul-
tidrug-resistance; (3) the decreased metabolic 
activity due to the top-bottom gradients of 
oxygen and nutrients and the related prolonged 
doubling time of microbial cells; (4) the aspecific 
binding of antimicrobial molecules with micro-
bial catabolites; (5) the emergence of dormant 
and persister cells. in this regard, it should be 
remembered that most of the studies have been 
carried out in vitro on single-species biofilms.
to overcome the difficulties encoun-
tered in the antimicrobial treatment of 
biofilm-associated infections, alternative 
approaches based on specific agents able to 
disrupt mature biofilms or to interfere with 
quorum sensing phenomena have been pro-
posed. among those experimented in the 
recent years, the most promising agents seem 
to be the matrix-disrupting enzymes Dispersin 
B and alginate lyase while different molecules 
extracted from natural sources are under inves-
tigation as possible quorum sensing inhibitors.
finally, a serious health issue is represented 
by the increasing occurrence of infections 
related to the implant of medical devices, 
including dental prostheses, catheters, stents 
and orthopedic prostheses.
Our team is currently involved in research 
projects addressing some aspects of the above 
mentioned open issues: (1) the ability of anaer-
obic bacterial species isolated from clogged 
biliary stents to form dual-species biofilms; (2) 
the in vitro study on the efficacy of antibiotics 
reported to be more active as “biofilm killers” 
and the possible synergistic role of matrix-
disrupting enzymes; (3) the development of 
novel anti-biofilm coatings able to counteract 
microbial adhesion and biofilm formation on 
medical device surfaces.
Study of biofilm formation by foodborne pathogenic and technological bacteria on model stainless 
steel surfaces, under monospecies and dual-species conditions, and evaluation of resistance of these 
sessile communities to chemical disinfectants
Efstathios Giaouris,1,* Nikos Chorianopoulos,2 Maria Kostaki3 and George-John Nychas3; 1Department of Food Science and Nutrition; University of Aegean; Myrina, 
Greece; 2Veterinary Research Institute; National Agricultural Research Foundation (NAGREF); Aghia Paraskeui; Athens, Greece; 3Agricultural University of Athens; 
Department of Food Science and Technology; Laboratory of Microbiology and Biotechnology of Foods; Athens, Greece; *Email: stagiaouris@aegean.gr
Biofilm formation is a natural phenomenon 
that happens almost wherever microorgan-
isms and surfaces exist in close proximity. 
attachment of pathogenic bacteria onto food-
contact surfaces and subsequent biofilm for-
mation is undesirable, since detachment of 
cells from biofilm structure can lead to cross-
contamination of food products and cause 
foodborne diseases. the risk becomes even 
more serious since bacteria enclosed in bio-
films have been shown to express increased 
resistance to many antimicrobial treatments 
compared with their planktonic counterparts. 
in the majority of natural environments, mono-
species biofilms are relative rare. conversely, 
microorganisms are associated with surfaces 
in complex multispecies communities. in the 
food industry of fermented products (dairy, 
fermented sausages, vegetables etc), mixed 
bacterial biofilms may contain strains ben-
eficial to the safety and quality of the final 
product (e.g. lactobacilli and staphylococci). in 
the present study, the ability of nine bacterial 
strains to form biofilms onto model stain-
less steel surfaces was studied. these strains 
were selected from totally 30 strains that had 
been initially screened for biofilm formation 
on different abiotic substratums under various 
environmental conditions. they belonged to 
the well-known foodborne pathogens Listeria 
monocytogenes and Salmonella enterica, as 
well as to the useful species Lactobacillus sakei. 
Strains of L. sakei are nowadays used for the 
production of fermented meat products in 
many European countries. three strains were 
employed for each species and cells were 
left to form biofilms, at 15°c and 30°c, under 
two different mixed-culture conditions; that is 
either three strains of same species together, 
or six strains of two different species together. 
it is believed that microbial interactions influ-
ence the biofilm forming capacity of indi-
vidual strains, as well as their resistance to 
antimicrobial treatments. however, present 
results did not reveal any significant differ-
ences at the levels of biofilm populations 
for each bacterial species separately, among 
the two different culture conditions (mono-
species, dual-species). the minor differences 
which were observed were found to be depen-
dent on both the species employed and the 
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incubation temperature (15, 30°c). afterwards, 
the disinfection ability of three common 
chemical antimicrobial compounds (benzal-
konium chloride 50 ppm, chlorine 10 ppm 
and peracetic acid 10 ppm) against biofilm 
cells was studied. under current conditions, 
L. monocytogenes presented higher resistance 
to the three disinfectants compared to the 
other two bacterial species. Not important 
differences, with regard to antimicrobial resis-
tance of the three bacterial species separately, 
were revealed among the two different cul-
ture conditions (monospecies, dual-species). 
present study offers important knowledge on 
the abilities to form and eliminate bacterial 
biofilms, under conditions simulating real food 
processing environments. in the future, we 
plan to evaluate the individual contribution 
of each strain both in the formation of the 
complex biofilm community, as well as in the 
resistance of it to antimicrobials.
Electro-active biofilms: When microbiology and electrochemistry meet
Benjamin Erable; CNRS; Toulouse, France; Email: Benjamin.Erable@ensiacet.fr
Microbial fuel cells (Mfc) can transform the 
chemical energy from cheap organic com-
pounds directly into electrical energy. the 
concept was known since the 70s, but with 
little prospect of industrial development in the 
short or medium term. a fundamental break-
through occurred in 2002: the unexpected 
discovery of microorganisms capable of cata-
lyzing the oxidation process at the surface 
of graphite electrodes. these microorganisms 
can attach spontaneously to the surface of 
materials and form a three-dimensional struc-
ture more or less organized called electro-
active biofilm (EaB). the EaBs can be formed 
artificially in laboratory from pure culture of 
microorganisms (Geobacter sulfurreducens, 
Rhodoferax ferrireducens, Shewanella oneiden-
sis, etc.) or can develop spontaneously on 
electrodes immersed in natural environments 
rich in microorganisms such as sediments or 
sludge from wastewater treatment plants. With 
this new type of electro-catalysis assisted by 
microorganisms, the Mfc technology produce 
electrical energy by oxidizing a large diver-
sity of organic compounds (acetate, volatile 
fatty acids, saccharides...) contained in natural 
environments. currently, EaB catalyzing reac-
tions of microbial electro-oxidation are the 
most commonly studied by the international 
scientific community working on Mfc. at 
the “Laboratoire de génie chimique” (cNrS – 
university of toulouse), a new field of research 
was opened on microbial catalysis of oxy-
gen electro-reduction following the progress 
achieved in the field of biocorrosion. indeed, 
marine EaBs able to catalyze the electrochemi-
cal reduction of oxygen have been detected 
from seawater subsurface in 2005.1 the recon-
struction of this type of marine aerobic EaB 
was then perfectly controlled in laboratory five 
years later, in 2010.2 in the same time, culture-
dependant isolations led to the identification 
of three pure electro-active strains catalyzing 
the oxygen electro-reduction on stainless steel 
electrodes with performances similar to the 
oxygen electro-reduction on a pure platinum 
electrode.2
Now the project is to develop the research 
on these aerobic EaB beyond the current 
knowledge in two complementary ways:
• Building the necessary basic knowledge 
on “Stainless Steel/EaB” interfaces. the tools of 
microscopy and molecular biology will then be 
combined to understand how EaB is structur-
ing on the surface of stainless steels. advanced 
techniques in electrochemistry at the local level 
(as SVEt for example) will be used to pierce the 
mysteries of electron transfer between microor-
ganisms and the surface of stainless steel.
• Using these fundamental advances in 
designing optimal microbial cathodes that will 
lead the Mfc technology to a pre-industrial 
development. the combination of different 
scales of electrodes structuring (nano- and/or 
micro-structuring) to promote bacterial adhe-
sion and the electron transfer is an original 
approach to maximize the catalytic perfor-
mance of the interfaces. also, a strategy com-
bining the stabilization of the reaction and 
the improvement of mass transport inside he 
biofilm structure should consistently improve 
the stability of microbial cathodes.
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Is Candida spp. biofilm eradication possible in vitro? 
Christine Imbert; Laboratoire de Chimie et Microbiologie de l’eau; UMR CNRS 6008; Faculté de Médecine et Pharmacie; University of Poitiers; Poitiers, France; 
Email: christine.imbert@univ-poitiers.fr
Candida species represent the fourth most 
common cause of nosocomial bloodstream 
infections. the management of candidiasis 
associated with catheters remains difficult 
since these medical devices can act as sub-
strates for biofilm growth. fungal biofilm is a 
complex phenomenon that may occur within 
three days of catheterization. Candida spe-
cies, especially C. albicans, are the most com-
mon fungal species associated with biofilms. 
Different approaches which could contribute 
to the prevention or inhibition of candida 
biofilms associated with invasive indwelling 
medical devices or superficial devices have 
been developed and evaluated. this talk deals 
with the strategies which could contribute 
to fight candida biofilms in vitro. We espe-
cially investigated C. albicans, C. glabrata and 
C. parapsilosis species because of their major 
implication in device-related candidiasis. Our 
studies tried to mimic three inhibition strate-
gies able to prevent Candida spp. adherence 
and/or subsequent biofilm formation. the 
first one corresponded to long-term systemic 
therapy (at least 24 h) using antifungal agents; 
some of them could significantly inhibit bio-
films with different maturation ages. this strat-
egy mimicked a curative way. the anti-biofilm 
interest of natural compounds, especially 
terpenic derivatives, was also investigated in 
this way. the second one was to prevent or 
delay fungal colonization in vitro, by coating 
or grafting active compounds on the cath-
eter surface. antiseptic as well as antifungal 
agents and natural compounds have been 
tested. this second strategy corresponded to 
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a prophylactic way. finally, the third one cor-
responded to the use of antifungal lock solu-
tions. the antifungal-lock technique involves 
in vitro the static instillation of a concentrated 
solution of antifungal agent (corresponding to 
100–500 Mic) into the catheter, and allowing 
it to remain for an extended period, usually no 
more than 12 h. it could represent a logical step 
to prevent colonization of long term devices 
and thereby reduce the rate of catheter related 
bloodstream infections. this one could also be 
used in a curative approach, if associated with 
systemic therapy. in conclusion, Candida spp. 
biofilm inhibition involves in vitro a lot of vari-
ous approaches and we can hope that some 
of these will really contribute to reduce fungal 
in vivo colonization and prevent candidiasis 
associated with medical devices. however, our 
in vitro results suggested that once the 
Candida spp. biofilms were developed on 
the device surface, it was quite impossible to 
obtain their overall eradication, whatever the 
used approach, suggesting the possible inter-
est to use combined strategies.
Bacterial-fungal interactions and new model hosts for the study of biofilms
Eleftherios Mylonakis; Editor-in-Chief; Virulence; and Harvard Medical School; Boston, MA USA; Email: emylonakis@partners.org
Candida albicans is an important cause of mor-
bidity in hospitalized and immunosuppressed 
patients. Virulence factors of C. albicans include: 
filamentation, proteinases, adherence proteins 
and biofilm formation. prokaryote-eukaryote 
interactions are ubiquitous and have impor-
tant medical and environmental significance. 
although bacterial-fungal interactions shape 
microbial virulence during polymicrobial infec-
tions in biofilms, a limited number of studies 
have evaluated this interaction on a genetic 
level. We have developed a novel alterna-
tive to study microbial pathogenesis and host 
responses: the use of invertebrate model hosts 
and especially the nematode Caenorhabditis 
elegans. Candida albicans and the gram-
negative bacterial pathogen Salmonella 
enterica serovar typhimurium are patho-
genic to the nematode Caenorhabditis ele-
gans. We observed that when C. elegans is 
infected with C. albicans and S. typhimurium, 
C. albicans filamentation is inhibited. 
importantly, the antagonistic interaction was 
also observed in a C. albicans biofilm environ-
ment.1 the interaction is mediated by sopB, an 
effector of a type iii secretion system (ttSS) 
of S. typhimurium . using quantitative real 
time-pcr assays, we found that the candida 
supernatant upregulated the S. typhimurium 
genes associated with C. albicans killing (sopB 
and sipB). interestingly, the sopB effector neg-
atively regulated the transcription of cDc42, 
which is involved in fungal viability.2 Similarly, 
in vitro coinfection assays in planktonic and 
biofilm environments supported the inhibi-
tory effects of Acinetobacter baumannii toward 
C. albicans.3
Moreover, there is an urgent need for 
the development of new agents with activ-
ity against biofilms. however, antimicrobial 
drug discovery has been limited by numer-
ous obstacles including the failure to iden-
tify new cultivable microorganisms, a high 
background of toxic compounds or com-
pounds with poor pharmacokinetic proper-
ties in synthetic compound libraries and the 
inability of most synthetic leads to penetrate 
across the multidrug resistance (MDr) pump 
barrier of gram-negative bacteria. We have 
bypassed some of these obstacles by devel-
oping whole-animal high-throughput screens 
that utilize C. elegans as a model host to 
simultaneously identify new classes of antimi-
crobials with antivirulence or immunomodu-
latory efficacy and evaluate toxicity/efficacy. 
We devised a candida-mediated C. elegans 
assay that allows high-throughput in vivo 
screening of chemical libraries for antifun-
gal activities, while synchronously screening 
against toxic compounds. compounds identi-
fied in the screen that affect the virulence of 
candida in vivo can potentially be used as 
“probe compounds” and may have antifun-
gal activity against other fungi. importantly, 
C. albicans hyphae and biofilm formation 
were also disrupted in the presence of natural 
products identified through these screens.4 
in conclusion, our investigations have identi-
fied novel virulence factors, cross kingdom 
pathogen-pathogen interactions and evolu-
tionarily conserved traits that are involved in 
biofilm formation.
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Efficacy of a Staphylococcus aureus biofilm-embedded bacterin against coagulase-negative staphylococci 
intramammary infections in dairy cows
Antoni Prenafeta; R&D; HIPRA S.A.; Amer, Spain; Email: apa@hipra.com
Mastitis is the most important disease in dairy 
cattle, including both clinical and subclinical 
infections, that affects quality and quantity of 
milk and is accompanied by increased health 
care costs, higher culling rates and sometimes 
even death.
intramammary infections are usually initi-
ated either by colonization of the teat canal 
with bacteria derived from infected epidermis 
or by an influx of contaminated milk entering 
the gland in milking machines.
Many chronic infections are associated 
with a bacterial growth in the form of adher-
ent colonies surrounded by a extracellular 
matrix, constituting a biofilm. Because of their 
aggregate size, biofilms are not susceptible 
to macrophage or neutrophil phagocytosis 
and become resistant to some antibiotics. 
On the other hand, detachment of biofilm 
bacteria cells is a cause of new colonizations, 
while the production of endotoxins and exo-
toxins (within the biofilm and by detached 
planktonic cells) produce inflammation and 
tissue damage.
Various studies have demonstrated the in 
vitro biofilm formation ability in the main 
pathogens isolated from bovine mastitis: 
Staphylococcus aureus,1-3 Escherichia coli4 and 
Streptococcus uberis.5 With regard to coag-
ulase-negative staphylococci (cNS) isolated 
from bovine mastitis (the most frequently iso-
lated bacteria in cows’ milk samples), the in 
vitro biofilm formation have been determined 
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in S. epidermidis2 and other coagulase- 
negative species.6
the aim of this study was to characterize 
the cNS species isolated from cows included 
in a field trial to check the efficacy of Startvac© 
vaccine in a commercial dairy herd with sub-
clinical cNS mastitis problems. the Startvac© 
vaccine contains a bacterin from a strong 
biofilm producing S. aureus strain expressing 
Saac (Slime associated antigenic complex).7 
a total of 331 healthy lactating cows and 
heifers with somatic cell counts lower than 
150,000 cells/ml were randomized to receive 
either vaccine or placebo. the animals were 
milk sampled on a monthly basis for five 
months, for enumeration of somatic cell count 
(Scc). in those animals showing Scc > 150,000 
cells/ml, california Mastitis test (cMt) was 
performed by quarter. cMt-positive quarters 
were sampled for microbiological analysis, 
and followed up until they had two consecu-
tive negative isolations. a total of 93 cNS were 
isolated: 64 in the placebo group and 29 in 
the vaccinated group. all the 93 cNS isolates 
were examined for the in vitro slime produc-
tion ability by the congo red agar (cra) plate 
test: slime production was detected in the 
37% of the control group isolates and in the 
31% of the vaccinated isolates. cNS were also 
identified to the species level by means of 
tDNa-pcr. 
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Towards understanding gene expression in multispecies biofilms containing Salmonella typhimurium
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Salmonella is still one of the most impor-
tant food-borne pathogens causing millions 
of infections each year. an important prob-
lem of Salmonella infections is the fact that 
the pathogens are frequently incorporated in 
surface-bound multicellular structures, i.e. bio-
films, which are difficult to combat. currently 
used anti-biofilm strategies are often not 
effective against these biofilms due to dif-
ferences in global gene expression and reg-
ulation patterns as compared to planktonic 
cells. Moreover, in situ biofilms exist of more 
than one microbial species. these multispe-
cies characteristics make metabolic regula-
tions and gene expression profiles even more 
complex. in order to develop novel anti- 
Salmonella therapeutics, also effective against 
biofilms, profound insight in these processes 
under these alternative physiological states 
(i.e. monospecies as well as multispecies) is 
needed. as such, our research focuses on the 
expression patterns of Salmonella typhimurium 
genes in monospecies and multispecies bio-
films. previous studies in monospecies S. 
typhimurium biofilms using the Differential 
fluorescence induction (Dfi) technique iden-
tified 26 promoter fusions showing biofilm-
specific upregulation.1 the major advantage 
of performing this type of a genome-wide 
screening is the generation of data on sin-
gle cell level instead of a mean value for the 
whole population. this way, the heterogene-
ity, which is inherent to biofilms, can be taken 
into account. this heterogeneity is even more 
important in complex in situ biofilms contain-
ing multiple species. therefore, we are using a 
library of defined promoter constructs (from 
previous in house research as described in 
ref. 1 and literature) in a model multispecies 
biofilm containing two S. typhimurium sero-
types and Escherichia coli. Moreover a genome-
wide study, identical to the Dfi monospecies 
research, is being optimized in this specific 
multispecies context. Due to the effects of the 
complex hetergenous environment in such 
multispecies biofilms, a change in gene expres-
sion patterns and regulation is to be expected, 
as our preliminary results indicate. this way, 
it becomes possible to discriminate between 
genes that are important (i.e. upregulated or 
downregulated) during biofilm formation in 
general and genes that are specifically involved 
in biofilms with a certain microbial composi-
tion. hereto, we will not only use the above 
mentioned model multispecies biofilm, but we 
will also try to reconstitute (qualitatively and 
quantitavely) in situ biofilms, especially from 
the food processing industry. identified upreg-
ulated genes (and their products) in biofilms 
can lead to new targets to combat biofilms. 
therefore, knowledge generated during this 
research can help the identification and ratio-
nal design of potential biofilm-inhibiting mole-
cules, that specifically target biofilm formation.
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Developed microbial biofilms for sustainable agriculture
Gamini Seneviratne; Insitute of Fundamental Studies; Kandy, Sri Lanka; Email: gaminis@ifs.ac.lk
conventional agricultural systems have been 
threatened by indiscriminate use of chemical 
inputs in the long run. consequently, they have 
depleted the beneficial microbial communities 
resulting in declined soil fertility and low crop 
productivity. this study examined the effect 
of developed microbial biofilms with N2 fixers 
on restoration of soils deteriorated by conven-
tional agricultural practices in tea cultivation. 
the lower chemical fertilizer applications (i.e. 
reducing recommended chemical fertilizer use 
by 50%) coupled with the biofilm-based biofer-
tilizers known as biofilmed biofertilizers (BfBfs) 
increased biological nitrogen fixation signifi-
cantly. Simultaneously it increased soil micro-
bial biomass and decreased soil NO3- and pest 
infestation. further, the combined application 
significantly increased soil organic c by 20%, 
and reduced leaf transpiration by 40%. it also 
supported plant growth, rhizoremediation and 
soil moisture conservation in comparison to 
the 100% chemical fertilization. it is apparent 
from this study that replenishing the depleted 
soil microbial communities by applying such 
biofertilizers is likely to be beneficial in agro-
ecosystems with chemical N fertilizer use, if 
they are to be sustained for crop production.
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Developed microbial biofilms: A novel rhizoremediation tool to heal soil sickness
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in Sri Lanka, tea [Camellia sinensis (L.) O. kuntze] 
is the main agricultural foreign exchange 
earner. however, dieback of tea bushes and 
yield decline have been reported from some 
tea estates in many regions of the country. it 
is hypothesized that this is due to collapse of 
beneficial soil microbial communities under 
conventional agriculture and gradual accu-
mulation of phytotoxic allelochemicals in the 
tea soil. this study was done to investigate 
the effect of application of developed micro-
bial communities like Biofilmed Biofertilizers 
(BfBfs) on soils with phytotoxic allelochemicals. 
to evaluate the phytotoxic effect, lettuce seed 
germination test was employed with BfBfs 
treated and untreated soil samples which 
were collected from affected tea estates. then 
organic solvent extracts of above soils were 
subjected to fourier transform infrared (ftir) 
analysis. finally, accumulations of allelopathic 
phytotoxins in drought conditions were simu-
lated in the laboratory using pEg 6000, and 
plant responses were measured. the lettuce 
seed germination test in original soil sam-
ples showed zero or low germination (0-17%), 
while BfBfs treated soil samples showed 
significantly high germination percentage (73-
84%). in the ftir spectra, the untreated soil 
gave a peak at 1744 cm-1 that is responsible 
for a quinone that acts as an allelopathic phy-
totoxin, but BfBfs had evidently depleted the 
quinone, as reflected from the peak degrada-
tion of the spectra. thus, it is clear that the 
well developed microbial biofilms like BfBfs 
can revive the microbial diversity and action 
in tea soils, which help biodegrade the accu-
mulated allelopathic phytotoxins, and reduce 
the severity level of drought stress, favoring 
plant growth.
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the objective of our interdisciplinary research 
consortium is the development of anti-biofilm 
agents that specifically target bacterial bio-
films without affecting the planktonic growth 
of the bacteria. these specific anti-biofilm 
agents have the advantage of being less prone 
to the development of resistance than classical 
biocides or antibiotics. Moreover elucidation 
of their biofilm-specific mode of action reveals 
insights into the molecular events of biofilm 
formation and is likely to result in the iden-
tification of new cellular targets for biofilm 
inhibitors. the anti-biofilm agents have poten-
tial to be used in a preventive fashion (e.g. as 
coatings on medical implants and devices) or 
to eradicate biofilms (possibly in combination 
with antibiotics or disinfectants). Salmonella 
typhimurium, Pseudomonas aeruginosa and 
Escherichia coli are the model organisms, 
against which the anti-biofilm agents are 
being developed. Our development strategy 
consists of (1) in vitro and in silico screen-
ings of compound libraries for anti-biofilm 
agents, (2) chemical synthesis or purchase of 
a series of analogues of the identified hits, (3) 
structure-activity relationship studies (Sar) 
and structure-toxicity relationship studies, (4) 
mode of action studies of the lead compounds 
and (5) further evaluation and development 
of the lead compounds (e.g. synergy studies, 
use of more applied test systems, formulation, 
…). to this end a microbiological laboratory 
(cMpg), a laboratory for biomolecular model-
ing (BioMOL) and two chemistry groups (cOk, 
LOMac) of the k.u. Leuven are taking part in 
the consortium. 
results and perspectives 
• Brominated furanones have previously 
been shown to inhibit quorum sensing and 
biofilm formation of several bacterial species. 
We synthesized a library of 25 1’-substituted 
and -unsubstituted 3-alkyl-5-methylene-
2(5h)-furanones and 3-alkyl-maleic anhy-
drides, by using known and newly developed 
chemistry, and tested their effect against 
Salmonella biofilms. the most active fura-
nones have ic50 values around 1 mM. No 
evidence was found that furanones act on 
the currently known quorum-sensing systems 
in Salmonella. however, the furanones were 
found to interfere with the synthesis of flagella 
by Salmonella. interestingly, pretreatment 
with furanones rendered Salmonella biofilms 
more susceptible to antibiotic treatment.
• An in silico screening of the commer-
cial ‘Specs’ small molecule library revealed a 
2N-subsituted 2-aminoimidazoline as inhibi-
tor of biofilm formation. analogs with either 
a 2-aminoimidazoline or a 2-aminoimidazole 
scaffold were synthesized by using newly 
developed chemistry. among the 250 2-ami-
noimidazole-based compounds synthesized, 
(4)5-phenyl-2-amino-1h-imidazole was found 
to have a moderate inhibitory activity against 
Salmonella and pseudomonas biofilm forma-
tion. however, substitution of the N1-position, 
the 2N-position and the 4(5)-phenyl ring 
enhanced the activity up to 100 times (ic50 
~1 mM). furthermore, we demonstrated the 
biofilm inhibitory effect of the (2-hydroxy-
2,3-dihydro)-imidazo[1,2-a]pyrimidinium salts, 
the chemical precursors of the 2-aminoimid-
azoles (135 compounds). Mode of action stud-
ies revealed two possible cellular targets of the 
imidazoles, which are currently under further 
investigation. the 2-aminoimidazoles have 
been introduced in (1) a battery of anti-bio-
film challenge tests (with industrial partners) 
and (2) a project on anti-biofilm coatings for 
implants. 
• A high throughput screening of a library 
of >20,000 very diverse compounds (cD3) 
resulted in the identification of 140 anti-bio-
film agents. four compound families have 
been selected for which extensive Sar studies 
are currently being performed. furthermore, 
screening of a library of 672 novel peptides, 
isolated from mouse and man, resulted in the 
identification of fivepeptides with anti-biofilm 
activity.
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Biofilm growing intestinal anaerobic bacteria
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Sessile growth of anaerobic bacteria from the 
human intestinal tract has been poorly inves-
tigated even if recent literature data on obser-
vations by confocal laser scanning microscopy 
(cLSM) and experiments performed by using 
fluorescence in situ hybridization (fiSh) have 
reported that mucosal anaerobes, includ-
ing bacteroides and bifidobacteria, occur in 
microcolonies and are distributed throughout 
the mucus layer. Since very few facultative 
anaerobes can tolerate small levels of oxy-
gen concentration, the investigation on the 
development of anaerobic bacteria as bio-
film growing microbial communities is only 
obtainable by the use of appropriate gas 
mixtures in anaerobic cabinets, thus realizing 
the optimal conditions for their cultivation in 
complete absence of oxygen. Our group has 
recently reported data on the close associa-
tion existing between the clogging of biliary 
stents and the development in their lumen of 
a polymicrobial biofilm constituted by aerobic 
and anaerobic bacterial species other than by 
fungal species. presently, it is believed that 
microbial colonization of the inner surface 
of the stent plays a major role in the clog-
ging process. in fact, when a biliary stent is 
inserted across the sphincter of Oddi, the loss 
of the antimicrobial barrier represented by 
the sphincter itself and the low pressure in 
the common bile duct allow the reflux of duo-
denal content thus promoting an ascending 
microbial colonization. By using the clogged 
biliary stent as a model and exploiting the 
explanted stents as a generous source of 
biofilm growing anaerobes, our investigations 
have been focused on the in vitro ability of 
the isolated strains, belonging to the spe-
cies Bacteroides, clostridium, fusobacterium, 
peptostreptococcus, prevotella and Veillonella, 
to form biofilms. preliminarily, at least one 
strain belonging to each isolated species 
has been characterized for its ability to grow 
as biofilm by the in vitro slime production 
assay. then, field Emission Scanning Electron 
Microscopy (fESEM) and cLSM have been 
employed to observe and evaluate the mode 
of growth of both strong and weak slime-
producing strains and to analyze the tridimen-
sional structure of biofilms produced by the 
isolated anaerobic strains.
